Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 33 out of 100. Cognitive tests and assessment

Topic: Risk, prevention and care in population studies

Abstract Purpose Dementia is a condition with symptoms of memory decline, cognitive impairment, and difficulties in language and problem-solving, among others. Early screening of dementia conditions such as Alzheimer’s disease (AD) is fundamental for quick intervention and disease management. Currently used neuropsychological assessments are time-consuming as they contain many elements and require critical resources which are not always available. Other pathological assessments are invasive and not cost effective, hence identifying cognitive features for different dementia sub-groups during progression of the condition is crucial for clinicians. This study investigates this problem using a cost-effective data driven approach. Methods Using real cases and controls from the Alzheimer’s Disease Neuroimaging Initiative data repository (ADNI) who have undergone the Alzheimer’s Disease Assessment Scale-Cognitive 13 (ADAS-Cog), we conduct a feature-feature assessment together with Permutation Feature Importance (PFI) and machine learning algorithms to derive influential cognitive features for specific dementia groups from baseline diagnosis up to 36 months. Results Feature-feature analysis showed correlations between memory tasks such as Word Recall, Delayed Word Recall, and Word Recognition across both CN-MCI and MCI-AD groups. In contrast, low correlations for Naming, Command, and Ideational Praxis suggest they tap into distinct DSM-5 domains thus making them ideal for early screening. In addition, PFI results showed that Delayed Word Recall emerged as a top cognitive marker of progression in early stages, while Orientation gained prominence later thereby reflecting a shift toward executive and attentional decline. Conclusions The results of this study identified important relationships between cognitive features in the ADAS-Cog and provide a clear example of the value of data-driven machine learning approaches in the identification of markers that indicate disease progression in dementia.

Key findings

Why it matters

Using ADNI data, this study identified cognitive features linked to dementia progression, with Delayed Word Recall emerging as a top marker in early stages and Orientation becoming more prominent later. The aim is to find cost-effective cognitive features for screening and monitoring progression, not to treat, cure, or prevent Alzheimer's disease.

Study details

How this study scored 33/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 2 of 4; Institution's track record 0 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. Total 33 of 100.33 of 100 points earned67 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Health and Technology)
Journal's citation record 0 / 4 Health and Technology: journal h-index 56 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 4 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.3 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 2.5× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author David Peebles: h-index 21 (OpenAlex, whole career)
Institution's track record 0 / 3 University of Huddersfield: institution h-index 265 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 2 institution(s) in 2 countries
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Total 33 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Thabtah, F., & Peebles, D. (2025). Cognitive feature evaluation for disease progression in dementia and its precursors using feature selection. Health and Technology. https://doi.org/10.1007/s12553-025-01006-1

Vancouver

Thabtah F, Peebles D. Cognitive feature evaluation for disease progression in dementia and its precursors using feature selection. Health and Technology. 2025. doi:10.1007/s12553-025-01006-1.

BibTeX

@article{thabtah2025-d6e5e6fc,
  author  = {Thabtah, Fadi and Peebles, David},
  title   = {{Cognitive feature evaluation for disease progression in dementia and its precursors using feature selection}},
  journal = {Health and Technology},
  year    = {2025},
  doi     = {10.1007/s12553-025-01006-1},
  url     = {https://doi.org/10.1007/s12553-025-01006-1}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Cognitive tests and assessment

Similar studies

More on Cognitive tests and assessment

See all studies in Cognitive tests and assessment →